HoshinoT, OhtaA, YangD. Elevated serum interleukin-6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease (letter). J Rheumatol1998; 25:396–8.
2.
DavisJP, CainGA, PittsWJ, MagoldaRL, CopelandRA. The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochemistry1996; 35:1270–3. DOI 10.1021/bi952168g
3.
ElkayamO, YaronI, Shirazi1, JudovitchR, CaspiD, YaronM. Active leflunomide metabolite inhibits interleukin 1β, tumour necrosis factor a, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann Rheum Dis2003; 62:440–3. DOI 10.1136/ard.62.5.440
4.
PirildarT. Treatment of adult-onset Still's disease with leflunomide and chloroquine combination in two patients (letter). Clin Rheumatol2003; 22:157. DOI 10.1007/s10067-002-0667-0
5.
CefleA. Leflunomide and azathioprine combination in refractory adult-onset Still's disease. Ann Pharmacother2005; 39:764–7. Epub 1 March 2005. DOI 10.1345/aph.1E425
